■ 刊行論文
原著
|
1.
|
Ishihara T, Koyama A, Atsuta N, Tada M, Toyoda S, Kashiwagi K, Hirokawa S, Hatano Y, Yokoseki A, Nakamura R, Tohnai G, Izumi Y, Kaji R, Morita M, Tamura A, Kano O†, Aoki M, Kuwabara S, Kakita A, Sobue G, Onodera O:
SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan.
BMC Medical Genomics
17
(1)
:263
, 2024
|
2.
|
Yanagihashi M†, Hirayama T†, Shibukawa M†, Nagasawa J†, Fujita K, Izumi Y, Morita M, Bokuda K,Takahashi K, Kanai K, Atsuta N, Iguchi Y, Katsuno M, Murakami Y†, Mitsumoto H, Kano O†:
Reliability and consistency of the Japanese version of the Primary Lateral Sclerosis Functional Rating Scale.
BMC neurology
24
(1)
:282
, 2024
|
3.
|
Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Murakami T, Hanajima R, Kataoka H, Kiriyama T, Nanaura H, Sugie K, Hirayama T†, Kano O, Nakamori M , Maruyama H, Haji S, Fujita K, Atsuta N, Tatebe H, Tokuda T, Takahashi N, Morinaga A,Tabuchi R, Oe M, Kobayashi M, Lobello K, Morita S, Sobue G, Takahashi R, Inoue H:
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study.
BMJ Open
14
(10)
:e082142
, 2024
|
4.
|
Ebina J†, Mizumura S†, Shibukawa M†, Morioka H†, Nagasawa J†, Yanagihashi M†, Hirayama T†, Ishii N†, Kobayashi Y, Inaba A, Orimo A, Kano O†:
Comparison of MIBG uptake in the major salivary glands between Lewy body disease and progressive supranuclear palsy.
Clin Park Relat Disord
:
, 2024
|
5.
|
Nagasawa N†, Matsuoka A†, Ogawa M†, Shibukawa M, Kano O†:
Bow Hunter's Stroke Caused by Cryptic Recanalization of an Occluded Vertebral Artery: A Case Report.
Cureus
:
, 2024
|
6.
|
Yanagihashi M†, Okamoto R, Matsuoka A, Morioka H†,Fukuo A, Wada K†, Kano O†:
Unilateral Vocal Cord Paralysis in a Patient with Anti-Galactocerebroside Antibodies: A Case Report.
Journal Of Nippon Medical Shool
91
(4)
:422
-424
, 2024
|
7.
|
Hirayama T†, Morioka H†, Sugisawa T†, Shibukawa M†, Ebina J†, Hanashiro S†, Nagasawa J†, Yanagihashi M†, Okuni I†, Nakajima T, Murakami Y†, Yamanaka K, Ebihara S, Kano O†:
A preliminary study on the effects of long-term robot suit exercise training on gait function and quality of life in patients with spinal and bulbar muscular atrophy.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
:
, 2024
|
8.
|
Sawada M†, Hirayama T†, Yanagihashi M†, Fukushima K, Izumi Y, Naoi T, Morita M, Warita H, Aoki M, Iguchi Y, Katsuno M, Ogawa N, Urushitani M, Ishihara T, Onodera O, Murakami Y, Mitsumoto H, Kano O†:
Reliability study for the Japanese version of the Columbia Muscle Cramp Scale in amyotrophic lateral sclerosis.
Neurology and Clinical Neuroscience
:
, 2024
|
9.
|
keda A, Meng H, Taniguchi D, Mio M, Funayama M, Nishioka K, Yoshida M, Li Y, Yoshino H, Inoshita T, Shiba-Fukushima K, Okubo Y, Sakurai T, Amo T, Aiba I, Saito Y, Saito Y, Murayama S, Atsuta N, Nakamura R, Tohnai G, Izumi Y, Morita M, Tamura A, Kano O†, Oda M, Kuwabara S, Yamashita T, Sone J, Kaji R, Sobue G, Imai Y, Hattori N:
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis.
PNAS nexus
3
(8)
:pgae319
, 2024
|
総説及び解説
|
1.
|
狩野 修†:
本邦のドラック・ロスの現状と克服へのアプローチ.
医師と東京都医師会を結ぶ会報誌TMA 8月号
:15
-16
, 2024
|
2.
|
狩野 修†:
多職種診療連携による筋萎縮性側索硬化症患者の意思決定から外科手術の実際まで.
機関誌「神経治療学」
41
(3)
:324
-327
, 2024
|
3.
|
狩野 修†:
日本でも加速するALS遺伝子治療の動きと課題.
実験医学
:2183
-2184
, 2024
|
4.
|
狩野 修†, 平山 剛久†, 渋川 茉莉†:
多職種連携診療によるALS診療.
難病と在宅ケア
:25
-28
, 2024
|
5.
|
平山 剛久†, 森岡 治美†, 渋川 茉莉†,狩野 修†:
筋萎縮性側索硬化症のリハビリテーション,意思伝達装置の進歩.
脳神経内科
:202
-203
, 2024
|
症例報告
|
1.
|
Nagasawa J†, Ogawa M†, Konaka H†, Yanagihashi M†, Kano O†:
Emergency Mechanical Thrombectomy for Acute Middle Cerebral Artery Occlusion Accompanied by Adult-Onset Still's Disease.
Cureus
16
(4)
:e59196
, 2024
|
2.
|
Nagasawa J†, Ogawa M†, Konaka H†, Yanagihashi M†, Kano O†:
Emergency Revascularization for Acute Vertebral Artery Occlusion Accompanied by Systemic Lupus Erythematosus: A Case Report.
Cureus
16
(5)
:e60733
, 2024
|
3.
|
Yanagihashi M†, Okamoto R†, Matsuoka A†, Morioka H†, Fukuo A†, Wada K†, Kano O†:
Unilateral Vocal Cord Paralysis in a Patient with Anti-Galactocerebroside Antibodies: A Case Report.
Journal of Nippon Medical School
91
(4)
:422
-424
, 2024
|
4.
|
Morioka H†, Yanagihashi M†, Toda M, Ikeda T†, Mizuno M, Hori M†, Kamiya K†, Kano O†:
Isolated prosopagnosia caused by damage to the right inferior longitudinal fasciculus: a case report.
Journal of Nippon Medical School
:
, 2024
|
|
■ 学会発表
国内学会
|
1.
|
◎前川華澄, 渋川茉莉†, 扇谷昌宏, 稲嶺翔吾, 加藤隆弘, 狩野 修†, 山中宏二:
アルツハイマー病研究に向けたヒト血索来ミクログリア様細胞の遺伝子発現解析.
第43回日本認知症学会学術集会,
郡山市,
2024/11
|
2.
|
◎狩野 修†:
DIAにはじめて参加して.
第42回日本神経治療学会学術集会,
千葉市,
2024/11
|
3.
|
◎平山 剛久†, 森岡 治美†, 杉澤 樹, 松岡 彩之†, 横山 竜大†, 小川 麻喜子†, 小中 宏美†, 渋川 茉莉†, 蝦名 潤哉†, 花城 理依†, 長澤 潤平†, 柳橋 優†, 大国 生幸†, 海老原 覚, 狩野 修†:
球脊髄性筋萎縮症患者におけるロボットスーツを用いた運動訓練が歩行機能とQOLに及ぼす影響.
第42回日本神経治療学会学術集会,
千葉市,
2024/11
|
4.
|
◎狩野 修†, 平山 剛久†, 渋川 茉莉†, 蝦名 潤哉†, 長澤 潤平†:
今後のALS臨床試験を見据えたPatient and Pubic Involvement(PPI).
第42回日本神経治療学会学術集会,
千葉市,
2024/11
|
5.
|
◎狩野 修†:
ALSの国際間での連携.
第42回日本神経治療学会学術集会,
千葉市,
2024/11
|
6.
|
◎狩野 修†:
ALS臨床試験のためのガイドライン作成.
第42回日本神経治療学会学術集会,
千葉市,
2024/11
|
7.
|
◎狩野 修†、平山 剛久†:
ALS診療におけるリハビリテーション.
第36回日本リハビリテーション看護学会,
東京,
2024/10
|
8.
|
◎若井未央†,玉置優子†,梅村なほみ†,臼井健人†,佐久間淳也†,小瀧曜†,主原翠†,渋川茉莉†,大川瑞穂†,齊藤芙美†,狩野修†,緒方秀昭†,片桐由起子†:
双胎における遺伝学的検査の影響:当院で経験した2症例について.
第48回日本遺伝カウンセリング学会学術集会,
東京,
2024/08
|
国際学会
|
1.
|
◎Nakamura R, Tohnai G, Atsuta N, Ito D,Katsuno M, Izumi Y, Hirayama T†, Kano O†, Nakazato T, Hattori N, Hashimoto R,Aiba I, Shibuya K, Kuwabara S, Suzuki N, Aoki M, Oda M, Morita M, Doyu M,Sobue G, Japanese Consortium for Amyotrophic Lateral Sclerosis research Japanese Consortium for Amyotrophic Lateral Sclerosis research:
Clinical characteristics of amyotrophic lateral sclerosis with a SOD1 pathogenic variant in Japan.
The 65th JSN Meeting & AOCN2024,
Tokyo, Japan,
2024/06
|
2.
|
◎狩野 修†:
ALS治療の最新:ALSの近未来予測と克服課題.
The 65th JSN Meeting & AOCN2024,
Tokyo, Japan,
2024/05
|
3.
|
◎Hayashi N, Atsuta N, Nakamura R, Ito D, Katsuno M, Izumi Y, Nakazato T, Hattorii N, Tamura A, Hiyayama T†, Kano O†, Suzuki N, Aoki M, Morita M, Shibuya K, Kuwabara S, Sobue J, JaCALS:
Prognosis of using a non-invasive ventilation for ALS patients in a multicenter prospective cohort.
The 65th JSN Meeting & AOCN2024,
Tokyo, Japan,
2024/05
|
4.
|
Inoue H, Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Murakami T, Hanajima R, Kataoka H, Kiriyama T, Nanaura H, Sugie K, Hirayama T†, Kano O†, Nakamori M, Maruyama H, Haji S, Fujita K, Atsuta N, Takahashi N, Morinaga A, Tabuchi R, Oe M, Kobayashi M, Nagasawa T, Lobello K, Lungu C, Morita S, Sobue G, Takahashi R.:
Clinical trial of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic Lateral Sclerosis Medicine (iDReAM) study.
35th international symposium on ALS/MND,
Canada,
2024/12
|
5.
|
Nakamura R, Tohnai G, Atsuta N, Matsuda Y, Morimoto S, Ito D, Katsuno M, Izumi Y, Morita M, Iwata I, Yabe I, Nakazato T, Hattori N, Hirayama T†, Kano O, Tamura A, Suzuki N, Aoki M, Shibuya K, Kuwabara S, Oda M, MD, Hashimoto R, Aiba I, Ishihara T, Onodera O, Yamashita T, Ishiura H, Bokuda K, Shimizu T, Ikeda Y, Hasegawa K, Tanaka F, Yokota T, Kanai K, NotoZ Y, Kaji R, Niwa J, Doyu M, Okada Y, Okano H, Nakatochi M, Sobue G, on behalf of the Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS) study group:
Genetic modifier of age at onset in Japanese patients with amyotrophic lateral sclerosis.
35th international symposium on ALS/MND,
Canada,
2024/12
|
6.
|
Yanagihashi M†, Hirayama T†, Shibukawa M†, Nagasawa J†, Fujita K, Izumi Y, Morita M, Bokuda K, Takahashi K, Kanai K, Atsuta N, Iguchi Y, Katsuno M, Murakami Y†, Mitsumoto H, Kano O†:
Reliability and consistency of the Japanese version of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS).
35th international symposium on ALS/MND,
Canada,
2024/12
|
7.
|
◎Kano O†:
Respiratory Care Clinical and Research Workshop.
World Federation of Neurology Respiratory Working Group,
Canada,
2024/12
|
8.
|
◎Kano O†:
PANEL 2- PLS REGISTRIES AND BIOREPOSITORIES:
THINKING GLOBAL.
THE THIRD INTERNATIONAL PLS CONFERENCE,
Canada,
2024/12
|
9.
|
◎Kano O†:
PANEL 4- CRITICAL PATH TO CLINICAL TRIALS.
THE THIRD INTERNATIONAL PLS CONFERENCE,
Canada,
2024/12
|
10.
|
◎Morioka H†, Hirayama T†, Sugisawa T, Hayashi M, Shibukawa M†, Ebina J†, Nagasawa J†, Washizawa N†, Okuni I†, Ebihara S, Kano O†:
The impact of Robot-assisted training using Hybrid Assistive LimbⓇ in ALS patients.
The 2024 Annual NEALS Meeting,
Clearwater, FL,
2024/10
|
11.
|
◎Sawada M†, Hirayama T†, Yanagihashi M†, Fukushima K, Izumi Y, Naoi T, Morita M, Warita H, Aoki M, Iguchi Y, Katsuno M, Ogawa N, Urushitani M, Ishihara T, Onodera O, Murakami Y†, Mitsumoto H, Kano O†:
Reliability study for the Japanese version of the Columbia MuscleCramp Scale in amyotrophic lateral sclerosis.
The 2024 Annual NEALS Meeting,
Clearwater, FL,
2024/10
|
12.
|
◎Hirayama T†, Morioka H†, Sugisawa T, Shibukawa M†, Matsuoka A†, Ogawa M†, Konaka H†, Ebina J†, Hanashiro S†, Nagasawa J†, Yanagihashi M†, Okuni I, Ebihara S, Kano O†:
Effects of Robot-assisted treatment on gait ability and quality of life in ALS patients.
The 65th JSN Meeting & AOCN2024,
Tokyo, Japan,
2024/05
|
13.
|
◎Nagasawa J†, Matsuoka A†, Yokoyama T†, Ogawa M†, Konaka H†, Ebina J†, Shibukawa M†, Morioka H†,
Yanagihashi M†, Hirayama T†, Kano O†:
Small plaque lesions on CT angiography in patients with ESUS.
The 65th JSN Meeting & AOCN2024,
Tokyo, Japan,
2024/05
|
14.
|
◎Shibukawa M†, Hirayama T†, Morioka H†, Yokoyama T†, Tsuda H†, Bokuda K, Ogino M,Takao H,Morita M,
Takahashi Y, Nakamura R, Atsuta N, Yamanaka K, Izumi Y, Urushitani M, Kano O†:
Investigation on the awareness and usage of accessibility features of ICT devices among ALS patients.
The 65th JSN Meeting & AOCN2024,
Tokyo, Japan,
2024/05
|
15.
|
◎Ebina J†, Mizumura S, Morioka H†, Shibukawa M†, Nagasawa J†, Yanagihashi M†, Hirayama T†,
Ishii N, Kobayashi Y, Inaba A, Orimo S, Kano O†:
Comparisons of MIBG uptake in the major salivary glands between PD and atypical parkinsonism.
The 65th JSN Meeting & AOCN2024,
Tokyo,Japan,
2024/05
|
その他
|
1.
|
◎花城 里衣†, 狩野 修†, 堀 正明†:
ALSにおける脳MRIネットワーク解析を用いた微細構造変化の検出.
第164回東邦医学会例会プログラム,
東邦大学医学部 大森臨床講堂,
2024/06
|
2.
|
◎狩野 修†:
神経疾患克服へのロードマップ.
第164回東邦医学会例会プログラム,
東邦大学医学部 大森臨床講堂(5号館B1階),
2024/06
|
3.
|
◎柳橋 優†, 狩野 修†:
医学教育学を学びながら考えた問い〜医学生の学習意欲が変化する要因とその効果の分析〜.
第164回東邦医学会例会プログラム,
東邦大学医学部 大森臨床講堂,
2024/06
|
4.
|
◎狩野 修†:
ALSの近未来予測.
鶴見難病講演会,
横浜市,
2024/06
|
5.
|
Yanagihashi M†, Hirayama T†, Shibukawa M†, Nagasawa J†, Fujita K, Izumi Y, Morita M, Bokuda K, Takahashi K, Kanai K, Atsuta N, Iguchi Y, Katsuno M, Murakami Y†, Mitsumoto H, Kano O†:
The reliability and consistency of Japanese version Primary Lateral Sclerosis Functional Rating Scale (PLSFRS).
35th international symposium on ALS/MND,
Canada,
2024/12
|
6.
|
Yanagihashi M†, Hirayama T†, Shibukawa M†, Nagasawa J†, Fujita K, Izumi Y, Morita M, Bokuda K, Takahashi K, Kanai K, Atsuta N, Iguchi Y, Katsuno M, Murakami Y†, Mitsumoto H, Kano O†:
Reliability and consistency of the Japanese version of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS).
35th international symposium on ALS/MND,
Canada,
2024/12
|
|